Peter Hjelmström (born 1973) has been employed at Camurus since 2016 and was appointed Chief Medical Officer in 2020. He holds the overall medical responsibility for Camurus’ products both in development and on the market.
He has more than 15 years of experience within the pharmaceutical business, including previous positions as Medical Director at Orexo, Head of Clinical Science at Sobi and Medical Affairs Manager at Alexion Pharma. He has held clinical development medical director responsibilities in clinical trials from Phase 1 to 4 and medical affairs responsibilities for five product launches in both Europe, Australia and the US. Furthermore, he has more than 40 publications in peer-reviewed scientific journals and is named lead inventor on one patent.
Peter holds an MD, Ph.D. and Assoc. Prof. from Karolinska Institute and a Postdoctoral fellowship at Yale University.
Holdings in the company: 38,500 employee options.